Although Xu et al. [15] reported anti-prostate cancer effects of paeonol through modulating apoptosis via capspase-dependent and PI3K/Akt pathways in DU145 cell lines, its efficacy in BPH remains unexplored to the best of our knowledge. This evidence concerns the gene AKT1 and prostate carcinoma.